Physician profile
Joyce L Quick
NPI 1255588414
$2,543.23
in general payments reported to CMS, 2019-2025
13 companies · $69.29 in 2025
The $69.29 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $843 · 2022: $1,074 · 2023: $305 · 2024: $252 · 2025: $69.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $626.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $856.36 | 2021-2023 | |
| Qol Medical, LLC | $604.31 | 2023-2025 | Sucraid, Sucraid |
| Abbvie INC. | $464.10 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $212.15 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $114.41 | 2022 | |
| Ironwood Pharmaceuticals, INC | $64.84 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $43.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.74 | 2021-2022 | |
| Dynavax Technologies Corporation | $38.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.54 | 2021-2022 | |
| Redhill Biopharma INC. | $24.94 | 2021 | |
| Daiichi Sankyo INC. | $23.34 | 2022 | |
| Vifor Pharma, INC. | $20.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Quick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.